Levonorgestrel: Clinical Trials

159 trials of Levonorgestrel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

129 completed, 10 unknown, 7 recruiting, 5 terminated. 35 Phase 1, 30 Phase 3, 27 Phase 2, 27 Phase 4, 18 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 135Completed 33, Active not recruiting 1, Terminated 1
Phase 330Completed 20, Unknown 3, Not yet recruiting 2, Recruiting 2, Suspended 1, Terminated 1, Withdrawn 1
Phase 227Completed 18, Unknown 4, Recruiting 2, Active not recruiting 1, Suspended 1, Terminated 1
Phase 427Completed 24, Recruiting 1, Terminated 1, Unknown 1
Not applicable18Completed 12, Unknown 3, Recruiting 2, Not yet recruiting 1

Follow Levonorgestrel: new trials by email Literature Review of Levonorgestrel trials Research Report on Levonorgestrel

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Rct Assessing Pregnancy - Piroxicam for Ec With Levonorgestrel
Levonorgestrel 1.5 mg and Piroxicam 40 mg, Oral LNG + Placebo - Emergency Contraception, Contraception
Phase 3Not yet recruitingUniversity of Utah14582027-03-012026-03-04
Efficacy, Safety, and Tolerability of Levonorgestrel Vaginal System
Levonorgestrel - Contraceptive Usage
Phase 3Not yet recruitingChemo Research16002026-12-012026-07-29
Weight-loss Drug for Fertility-Sparing Treatment of Atypical Hyperplasia and Low-grade Cancer of the Endometrium
Wegovy, Mirena - Endometrial Cancer, Atypical Hyperplasia
Phase 2RecruitingGynOncTrials712026-09-172026-10-05
The Influence of Plan B® on Cardiovascular Health.
Plan B (Levonorgestrel), Placebo (gelatin capsule) - Female, Premenopausal
Not applicableRecruitingMcMaster University402026-07-222026-10-14
Effects of Copper Versus Levonorgestrel Intrauterine Devices on Mucosal Microbiota and Barrier Function Among Young African Women
Levonorgesterel Intrauterine system (LNG IUS), Copper T Intrauterine device (Cu-IUD) - Vaginal Microbial Diversity
Not applicableNot yet recruitingSeattle Children's Hospital1202026-07-012026-06-04
Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)
Ethinyl Estradioll/Levonorgestrel (EE/LNG), Bemnifosbuvir/Ruzasvir (BEM/RZR), Bemnifosbuvir/Ruzasvir (BEM/RZR) + Ethinyl Estradioll/Levonorgestrel (EE/LNG) - Healthy Volunteer Study
Phase 1CompletedAtea Pharmaceuticals, Inc.242025-12-042026-04-13
Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Levonorgestrel Intrauterine System, Norethindrone Acetate - Heavy Menstrual Bleeding, Bleeding Disorder
RecruitingOregon Health and Science University3002025-09-242025-12-17
A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
AZD6234, Ethinyl estradiol/Levonorgestrel (EE/LEVO), Acetaminophen (APAP) - Healthy Participants
Phase 1Active not recruitingAstraZeneca1002025-06-042026-10-13
Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation
Primary Cesarean Section, immediate postplacental insertion of a copper T380A intrauterine device, progesterone-only pills - Scar Niche, Myometrial Remodeling
Not applicableCompletedBenha University7502025-02-122026-02-27
Levonorgestrel-piroxicam Versus Ulipristal Acetate for Emergency Contraception
Levonorgestrel, Piroxicam, Ulipristal Acetate - Contraception
Phase 3RecruitingThe University of Hong Kong9802025-01-182026-05-14
Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens
Levonorgestrel, Mifepristone - Pregnancy Early, Pregnancy Related
Phase 2 / Phase 3UnknownGynuity Health Projects2862024-07-222024-07-18
A Research Study Looking Into the Effect of NNC0519-0130 on Blood Levels of a Birth Control Pill and Emptying of the Stomach in Women After Menopause
NNC0519-0130, Levonorgestrel + Ethinylestradiol, Paracetamol - Diabetes Mellitus, Type 2
Phase 1CompletedNovo Nordisk A/S472024-07-182026-03-12
Comparison of Two PPOS Models for Pituitary Suppression
Cerazet - Infertility, Female, Fertility Disorders
Not applicableUnknownNextFertility2102024-07-012024-06-18
A Research Study Looking at How the Compound NNC0487-0111 Works With Birth Control Pills and Affects Emptying of the Stomach in Women Not Able to Become Pregnant
NNC0487-0111 A, NNC0487-0111 C, Levonorgestrel 150 μg + Ethinylestradiol 30 μg (Oral contraceptive OC) - Obesity
Phase 1CompletedNovo Nordisk A/S432024-06-142025-05-08
A Research Study Looking at How the Compound NNC0194-0499 Works With Birth Control Pills in Women Not Able to Bear Children.
NNC0194-0499, ethinylestradiol/levonorgestrel - Healthy Volunteers (Non-alcoholic Steatohepatitis)
Phase 1CompletedNovo Nordisk A/S342023-12-182025-02-18
Phase II Study of Ovulation in Obese Women
Levonorgestrel 1.5 milligram, Meloxicam 15 milligram, calcium carbonate 750 milligram - Pregnancy Prevention
Phase 2CompletedInnovaGyn, Inc.42023-12-102026-06-30
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
Levonorgestrel 52 MG Intrauterine System - Contraception
Phase 4RecruitingUniversity of Utah14042022-11-072026-04-16
Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days
Levonorgestrel 1.5mg, Meloxicam 15 mg, Placebo - Pregnancy Prevention
Phase 2CompletedInnovaGyn, Inc.192022-06-282026-09-09
Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
Intensive Lifestyle Intervention (ILI), Megestrol Acetate 160 MG Oral Tablet, Levonorgestrel-Releasing Intrauterine Contraceptive System (Mirena), 52 Mg - Atypical Endometrial Hyperplasia, Fertility Issues
Phase 2 / Phase 3RecruitingXiaojun Chen1722022-06-132026-06-04
Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product
Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Microgynon CD - Therapeutic Equivalency
Phase 1CompletedLaboratorios Andromaco S.A.362022-02-262022-06-02

Showing 20 of 159. Sign in to see all of them.

Conditions studied

Menorrhagia (13)  ·  Endometriosis (6)  ·  Endometrial Hyperplasia (5)  ·  Obesity (5)  ·  Acquired Immunodeficiency Syndrome (4)  ·  HIV Infections (4)  ·  Amenorrhea (3)  ·  Diabetes Mellitus, Type 2 (3)  ·  Infertility (3)  ·  Adenomyosis (2)  ·  Anorexia Nervosa (2)  ·  Contraception Behavior (2)  ·  Diabetes Mellitus (2)  ·  Dysmenorrhea (2)  ·  Endometrial Neoplasms (2)

Sponsors

Bayer (35)  ·  University of Utah (6)  ·  Pfizer (5)  ·  FHI 360 (4)  ·  Novo Nordisk A/S (4)  ·  University of Colorado, Denver (4)  ·  AstraZeneca (3)  ·  Duramed Research (3)  ·  Laboratorios Andromaco S.A. (3)  ·  Oregon Health and Science University (3)  ·  University of Pittsburgh (3)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (3)  ·  Boehringer Ingelheim (2)  ·  Columbia University (2)  ·  Gynuity Health Projects (2)

Countries

United States (60)  ·  Germany (12)  ·  United Kingdom (10)  ·  Sweden (9)  ·  Canada (8)  ·  Spain (8)  ·  France (7)  ·  Brazil (6)  ·  Netherlands (6)  ·  Belgium (5)  ·  Kenya (5)  ·  Mexico (5)  ·  Norway (5)  ·  Chile (4)  ·  China (4)

Top investigators

Andrea Olariu, MD, PhD (2)  ·  David Turok, MD, MPH (2)  ·  Diana Blithe, PhD (2)  ·  Abimbola O. Famuyide, MBBS (1)  ·  Alicia Smith, PhD (1)  ·  Alison Edelman, MD (1)  ·  Alison Edelman, MD, MPH (1)  ·  Allison Wheeler (1)  ·  Andrea Lukes, MD (1)

Results publications

PMID 23114735, PMID 26830816, PMID 12441312, PMID 15471507, PMID 15541405, PMID 16009156, PMID 16102549, PMID 16798842, PMID 16855077, PMID 16980507, PMID 17077229, PMID 17434015, PMID 18653184, PMID 18929686, PMID 19698816, PMID 19933235, PMID 19955104, PMID 20034000, PMID 20116841, PMID 20378611, PMID 20472114, PMID 20733445, PMID 21074011, PMID 21417562, PMID 21475963, PMID 21632810, PMID 22222193, PMID 22429273, PMID 22959906, PMID 23040128, PMID 23340271, PMID 23512637, PMID 23562364, PMID 23635728, PMID 23744513, PMID 24388695, PMID 24682613, PMID 24713413, PMID 24726226, PMID 24785854, PMID 24835831, PMID 24986712, PMID 25129340, PMID 25242443, PMID 25259677, PMID 25283586, PMID 25385099, PMID 25393993, PMID 25504028, PMID 25934164

NIH funding

2018 (3), 2008 (2), 2017 (2), 2023 (2), 2004 (1), 2005 (1), 2014 (1), 2016 (1), 2019 (1), K12HD001271 (1), R01AI155052 (1), R01DE016212 (1), R01HD043869 (1), R01HD072663 (1), R01HD085887 (1)